Attached files
| file | filename |
|---|---|
| EX-32.2 - EX-32.2 - Urovant Sciences Ltd. | urov-ex322_8.htm |
| EX-31.2 - EX-31.2 - Urovant Sciences Ltd. | urov-ex312_13.htm |
| EX-31.1 - EX-31.1 - Urovant Sciences Ltd. | urov-ex311_11.htm |
| EX-23.1 - EX-23.1 - Urovant Sciences Ltd. | urov-ex231_7.htm |
| EX-21.1 - EX-21.1 - Urovant Sciences Ltd. | urov-ex211_9.htm |
| EX-10.22 - EX-10.22 - Urovant Sciences Ltd. | urov-ex1022_123.htm |
| EX-4.3 - EX-4.3 - Urovant Sciences Ltd. | urov-ex43_12.htm |
| 10-K - 10-K - Urovant Sciences Ltd. | urov-10k_20200331.htm |
Exhibit 32.1
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Annual Report on Form 10-K of Urovant Sciences Ltd. (the “Company”) for the period ended March 31, 2020 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), the undersigned, James Robinson, Principal Executive Officer of the Company, hereby certifies, pursuant to the requirement set forth in Rule 13a-14(b) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and 18 U.S.C. Section 1350, that to the best of his knowledge:
|
|
(1) |
The Report fully complies with the requirements of Section 13(a) or 15(d) of the Exchange Act; and |
|
|
(2) |
The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company. |
|
Date: June 19, 2020 |
|
By: |
|
/s/ James Robinson |
|
|
|
|
|
James Robinson |
|
|
|
|
|
Principal Executive Officer |
This certification accompanies the Form 10-K to which it relates, is not deemed filed with the Securities and Exchange Commission and is not to be incorporated by reference into any filing of the Company under the Securities Act of 1933, as amended, or the Exchange Act (whether made before or after the date of the Form 10-K), irrespective of any general incorporation language contained in such filing.